Stock Fundamentals

Company Information

Company Name
MaxCyte Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US57777K1060
CIK: 0001287098
CUSIP: 57777K106
Currency: USD
Full Time Employees: 91
Phone: 301 944 1700
Fiscal Year End: December
IPO Date: Jul 30, 2021
Description:

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. The company has strategic partnership with VectorBuilder focused on co-developing a new gene delivery solution. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Address:

9713 Key West Avenue, Rockville, MD, United States, 20850

Directors & Officers

Name Title Year Born
Mr. Maher Masoud President, CEO & Executive Director 1976
Mr. Parmeet Ahuja Chief Financial Officer 1969
Mr. Jay Gelfman Chief Operations Officer NA
Mr. Jack Horgan Senior Vice President of Corporate Development NA
Ms. Ana-Paula Martins Fernandes Senior Vice President of Global Sales NA
Ms. Jill Mayer Senior Vice President of Human Resources NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 17, 2026 Douglas J Swirsky N/A Sale 10.14K $0.81 $8.22K
Aug 13, 2025 Douglas J Swirsky N/A Purchase 50.00K $1.29 $64.50K
Aug 13, 2025 Maher Masoud N/A Purchase 75.00K $1.37 $102.75K
Aug 13, 2025 Richard Douglas N/A Purchase 80.00K $1.39 $111.20K
Aug 13, 2025 Stanley C Erck N/A Purchase 100.00K $1.37 $137.00K
Aug 13, 2025 William W Brooke N/A Purchase 50.00K $1.29 $64.50K
Jun 25, 2025 Rekha Hemrajani N/A Sale 10.68K $2.09 $22.33K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 8.80M Mar 31, 2026 8.21% $0.00 -4.81%
Capricorn Fund Managers Ltd 8.20M Mar 31, 2026 7.65% $0.90 0.00%
Vanguard Group Inc 5.54M Dec 31, 2025 5.17% $0.00 -0.87%
Vitruvian Partners 5.04M Mar 31, 2026 4.71% $3.17 0.00%
Vanguard Capital Management, LLC 3.98M Mar 31, 2026 3.72% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 3.69M Mar 31, 2026 3.44% $0.00 -16.82%
Mudita Advisors LLP 3.37M Mar 31, 2026 3.15% $0.48 0.00%
BNP Paribas Investment Partners SA 2.77M Mar 31, 2026 2.59% $0.00 0.00%
Geode Capital Management, LLC 2.36M Mar 31, 2026 2.21% $0.00 -6.18%
State Street Corp 2.19M Mar 31, 2026 2.05% $0.00 -6.99%
Brooklands Fund Management Limited 2.19M Mar 31, 2026 2.04% $1.73 0.00%
Renaissance Technologies Corp 1.99M Mar 31, 2026 1.86% $0.00 153.30%
Cadian Capital Management LP 1.72M Mar 31, 2026 1.61% $0.15 -53.22%
Peapod Lane Capital LLC 1.33M Mar 31, 2026 1.24% $0.76 0.00%
AQR Capital Management LLC 1.22M Mar 31, 2026 1.14% $0.00 1,199.49%
The Goldman Sachs Group Inc 1.16M Mar 31, 2026 1.08% $0.00 144.89%
Luminus Management, LLC 1.15M Mar 31, 2026 1.07% $0.49 386.27%
Stonepine Capital Management Llc 1.00M Mar 31, 2026 0.94% $0.28 114.21%
NANO CAP NEW MILLENNIUM GROWTH FUND L P 1.00M Mar 31, 2026 0.93% $0.66 334.78%
Vanguard Portfolio Management, LLC 889.24K Mar 31, 2026 0.83% $0.00 0.00%

Shares Statistics

Shares Outstanding: 107.12M
Shares Float: 97.63M
% Insiders: 159.30%
% Institutions: 6,818.50%
Short % Float: 1.43%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 RGI UK Listed Smaller Coms B Acc 3.80M 3.55% ▲ 15.15% May 31, 2026
2 AXA Framlington Health Fund - R Income 2.77M 2.59% ▲ 0.00% Apr 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 2.74M 2.56% ▲ 0.00% Apr 30, 2026
4 Unicorn AIM VCT Ord 2.49M 2.32% ▲ 0.00% May 31, 2026
5 iShares Russell 2000 ETF 2.46M 2.29% ▲ 0.93% May 29, 2026
6 Vanguard Institutional Extnd Mkt Idx Tr 1.17M 1.09% ▲ 0.00% Apr 30, 2026
7 Fidelity Small Cap Index 983.10K 0.92% ▼ 0.13% Mar 31, 2026
8 iShares Russell 2000 Value ETF 880.96K 0.82% ▲ 0.00% May 29, 2026
9 River UK Micro Cap Ord 834.10K 0.78% ▲ 0.00% Mar 31, 2026
10 MI Chelverton UK Equity Growth B Acc 700.00K 0.65% ▲ 0.00% May 31, 2026

Valuation Metrics

Enterprise Value: $52.57M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $142.47M
EBITDA: $-34.16M
Book Value: $1.57
Earnings/Share: $-0.36
Profit Margin: -121.16%
Operating Margin: -64.09%
ROA (TTM): -11.32%
ROE (TTM): -21.30%
Revenue (TTM): $32.29M
Revenue/Share (TTM): $0.30
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -7.10%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 8.30x 0.01x 0.15x N/A -0.04x
2024-12-31 10.88x 0.00x 0.14x N/A -0.02x
2023-12-31 10.65x 0.00x 0.13x N/A -0.02x
2022-12-31 16.35x 0.00x 0.11x -215.61x -0.01x
2021-12-31 17.32x 0.00x 0.07x -17.42x -0.03x
2020-12-31 3.90x 0.17x 0.36x -13.39x -0.56x
2019-12-31 2.62x 0.40x 0.55x -18.24x -0.47x
2018-12-31 3.42x 0.61x 0.49x -13.71x -0.95x
2017-12-31 4.22x 0.26x 0.38x -14.86x -0.55x
2016-12-31 2.79x 0.00x 0.68x -4.27x -0.01x
2015-12-31 1.22x -0.27x 1.48x -1.08x -1.27x
2014-12-31 1.41x -0.89x 1.26x -2.27x -1.24x
2013-12-31 0.58x -1.17x 1.62x -5.24x -2.62x
2012-12-31 0.77x -3.01x 1.21x -31.81x -0.98x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about MXCT.US!